Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
IL33 (MIM 608678) is a member of the IL1 (see MIM 147760) family that potently drives production of T helper-2 (Th2)-associated cytokines (e.g., IL4\; MIM 147780). Additionally we are shipping Interleukin 33 Antibodies (290) and Interleukin 33 Kits (78) and many more products for this protein.
Showing 10 out of 110 products:
Mouse (Murine) Interleukin 33 Protein expressed in Escherichia coli (E. coli) - ABIN2667522
Arend, Palmer, Gabay: IL-1, IL-18, and IL-33 families of cytokines. in Immunological reviews 2008
Show all 7 references for ABIN2667522
Human Interleukin 33 Protein expressed in Escherichia coli (E. coli) - ABIN2666662
Mildner, Storka, Lichtenauer, Mlitz, Ghannadan, Hoetzenecker, Nickl, Dome, Tschachler, Ankersmit: Primary sources and immunological prerequisites for sST2 secretion in humans. in Cardiovascular research 2010
Show all 6 references for ABIN2666662
Human Interleukin 33 Protein expressed in Escherichia coli (E. coli) - ABIN2002684
Cayrol, Girard: The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. in Proceedings of the National Academy of Sciences of the United States of America 2009
Show all 3 references for ABIN2002684
Human Interleukin 33 Protein expressed in Escherichia coli (E. coli) - ABIN1344110
Iikura, Suto, Kajiwara, Oboki, Ohno, Okayama, Saito, Galli, Nakae: IL-33 can promote survival, adhesion and cytokine production in human mast cells. in Laboratory investigation; a journal of technical methods and pathology 2007
Show all 3 references for ABIN1344110
Dog (Canine) Interleukin 33 Protein expressed in Escherichia coli (E. coli) - ABIN2008834
Schmitz, Owyang, Oldham, Song, Murphy, McClanahan, Zurawski, Moshrefi, Qin, Li, Gorman, Bazan, Kastelein: IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. in Immunity 2005
Show all 2 references for ABIN2008834
Targeting IL-33 was a promising strategy for controlling autoantibody production in AIHA patients
Data suggest that increased plasma Interleukin-33 (IL-33) levels in patients with rheumatoid arthritis (RA) could be a possible biomarker to reflect the potential risks of bone erosion.
IL13 (show IL13 Proteins) gene transcription can be directly activated by nuclear IL-33, which is negatively regulated by the deubiquitinase USP17.
IL-33(+) Muller cells were more abundant and IL-33 cytokine was elevated in advanced age-related macular degeneration cases compared with age-matched controls.
Results indicate that IL-33 may reversibly destabilize the endothelial barrier, thus accelerating the supply with immunomodulators and assisting leukocytes to reach wounded tissue.
No significant association between IL33 rs7025417, IL33 rs7044343, IL1RL1 (show IL1RL1 Proteins) rs2058660, IL1RL1 (show IL1RL1 Proteins) rs2310173 and IL1RL1 (show IL1RL1 Proteins) rs13015714 and cIMT values was observed.
Decreased expression of IL-33 in immune thrombocytopenia
high levels of IL-33 and a high IL-33/soluble ST2 (show SULT2A1 Proteins) ratio correlates with elevated levels of IFN-gamma (show IFNG Proteins), TNF-alpha (show TNF Proteins) and IL-17alpha as well as IL-5 (show IL5 Proteins), demonstrating that IL-33 has pleiotropic effects.
Study found higher levels of IL-33 and ST2 in HIV-1 clade B infected cells than in clade C infected cells
The results suggest that IL-33 may play a role in lung injury during severe malaria and lead to pulmonary edema.
pre-treatment with the ERK1/2 inhibitor U0126 or anti-IL-33 antibody significantly abolished the ovalbumin (show OVA Proteins)-induced airway remodeling, increased expressions of IL-33
IL-33 promotes degranulation of bone marrow-derived mast cells and release of cytokines IL-1beta (show IL1B Proteins), IL-6 (show IL6 Proteins) and TNF-alpha (show TNF Proteins).
pulmonary interstitial macrophages may not be a source of IL-33 during Respiratory syncytial virus infection
demonstrate a pathogenic role for IL-33-mediated eosinophilia and activation of Th2 immunity in chronic intestinal inflammation
IL-33 as a novel regulator of neutrophil function in antibacterial infection
Our results provide novel insights into the mechanism of action behind alum-induced cytokine responses and show that IL-33 is sufficient to provide a robust secondary antibody response independently of alum.
Results demonstrated that IL-33 was released by activated astrocytes actively, and by damaged neurons during experimental autoimmune encephalomyelitis
This study indicates a pathogenic role of alarmin IL-33 in a murine model of scrub typhus and highlights infection-triggered endothelial cell damage and IL-33-mediated pathological changes during the course of Orientia infection.
IL-33, an alarmin released in response to tissue damage, was secreted from vaginal epithelium after the depletion of commensal microbiota.
promotes muscle T reg (show KCNH2 Proteins) homeostasis in young mice, and efficient regeneration of injured muscles in aged mice
IL-33 may be a key molecule operating in eosinophil-mediated fibrosis in high-dose-per fraction irradiated skin.
IL33 (MIM 608678) is a member of the IL1 (see MIM 147760) family that potently drives production of T helper-2 (Th2)-associated cytokines (e.g., IL4\; MIM 147780). IL33 is a ligand for IL33R (IL1RL1\; MIM 601203), an IL1 family receptor that is selectively expressed on Th2 cells and mast cells (summary by Yagami et al., 2010
, DVS27-related protein
, interleukin-1 family member 11
, nuclear factor for high endothelial venules
, nuclear factor from high endothelial venules